Rigel Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Rigel Pharmaceuticals (RIGL).

Price Target Range — 12 Quarters

Analyst Consensus — 6 Analysts

3Buy

3Hold

Consensus RatingNeutral# Analysts6Avg. Consensus PT$53Upside to Avg. PT+10.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 19, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$85
Aug 17, 2026	Piper Sandler	Allison Bratzel	PT Raise	Neutral	$40→$49
Aug 14, 2026	HC Wainwright & Co.	Joseph Pantginis	PT Raise	Buy	$57→$85
Jun 2, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$57
May 27, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$57
May 22, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$57
May 13, 2026	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$69→$81
May 7, 2026	Citigroup	Yigal Nochomovitz	PT Cut	Buy	$71→$69
Nov 5, 2025	Jefferies	Eun Yang	Upgrade	Hold→Buy	$23→$42
Nov 5, 2025	Cantor Fitzgerald	Kristen Kluska	PT Raise	Neutral	$32→$38
Oct 8, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$57
Aug 6, 2025	Cantor Fitzgerald	Kristen Kluska	PT Raise	Neutral	$23→$32
May 7, 2025	Cantor Fitzgerald	Kristen Kluska	PT Raise	Neutral	$20→$23
Mar 6, 2025	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$49→$55
Mar 5, 2025	B. Riley Securities	Kalpit Patel	PT Raise	Neutral	$20→$24
Mar 5, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$57
Jan 23, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$57
Jan 14, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$57
Dec 10, 2024	Cantor Fitzgerald	Kristen Kluska	PT Raise	Neutral	$15→$25
Dec 10, 2024	B. Riley Securities	Kalpit Patel	PT Cut	Neutral	$27→$20

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $85 price target.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $49

Piper Sandler analyst Allison Bratzel maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and raises the price target from $40 to $49.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $85

HC Wainwright & Co. analyst Joseph Pantginis maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and raises the price target from $57 to $85.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $57 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $57 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $57 price target.

Benzinga Newsdesk

Rigel Pharmaceuticals Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Rigel Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target

PRO
Piper Sandler Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $49

PRO
HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $85

PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target

People Also Watch

People Also Watch

Rigel Pharmaceuticals Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Rigel Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target

PROPiper Sandler Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $49

PROHC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $85

PROHC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target

PROHC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target

PROHC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target

PRO
Piper Sandler Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $49

PRO
HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $85

PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target